SCHEMBL5147667

SCHEMBL5147667

CCNC(=O)C(N)c1cc[c]cc1

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.33
PRMT5 O14744 4/20 0.33
WDR77 Q9BQA1 4/20 0.33
RORA P35398 1/20 0.33
RORC P51449 1/20 0.33
GLS O94925 4/20 0.32
MALT1 Q9UDY8 2/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5144717 0.87 NAAA (0.37) KMT2ASMN1; SMN2
SCHEMBL4838617 0.82 PKM (0.57) PKMMEN1KMT2APRMT5WDR77
SCHEMBL3746577 0.82 PKM (0.57) PKMMEN1KMT2APRMT5WDR77
Hydrochloric Acid SCHEMBL28750033 0.81 PKM (0.55) PKMMEN1KMT2APRMT5WDR77
SCHEMBL9328613 0.81 ESR1 (0.42) PKMMEN1KMT2ASMN1; SMN2GAA
Hydrochloric Acid SCHEMBL4196019 0.81 PKM (0.55) PKMMEN1KMT2APRMT5WDR77
SCHEMBL27874655 0.80 FFAR2 (0.36) TSHRSMN1; SMN2RORARORCGLS
SCHEMBL996521 0.79 TSHR (0.54) TSHRMEN1KMT2ASMN1; SMN2MALT1
SCHEMBL27577102 0.77 ALDH1A1 (0.33)
SCHEMBL3535148 0.75 BRD4 (0.32) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES IL2, TSLP, IFNG PKM 2767/4885TSHR 240/4885MEN1 4176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.